ZA899961B - Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them - Google Patents

Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them

Info

Publication number
ZA899961B
ZA899961B ZA899961A ZA899961A ZA899961B ZA 899961 B ZA899961 B ZA 899961B ZA 899961 A ZA899961 A ZA 899961A ZA 899961 A ZA899961 A ZA 899961A ZA 899961 B ZA899961 B ZA 899961B
Authority
ZA
South Africa
Prior art keywords
fatty acid
saturated fatty
active substance
acid triglyceride
microgranulates
Prior art date
Application number
ZA899961A
Other languages
English (en)
Inventor
Jean-Claude Jamoulle
Jamoulle Jean-Claude
Josiane Allec
Allec Josiane
Alain Brzokewicz
Brzokewicz Alain
Braham Shroot
Shroot Braham
Original Assignee
Cird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cird filed Critical Cird
Publication of ZA899961B publication Critical patent/ZA899961B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA899961A 1988-12-29 1989-12-28 Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them ZA899961B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU87416A LU87416A1 (fr) 1988-12-29 1988-12-29 Microgranules charges en une substance active,constitues essentiellement d'un triglyceride d'acides gras satures et leur utilisation par voie topique dans le domaine therapeutique

Publications (1)

Publication Number Publication Date
ZA899961B true ZA899961B (en) 1990-10-31

Family

ID=19731128

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899961A ZA899961B (en) 1988-12-29 1989-12-28 Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them

Country Status (16)

Country Link
EP (1) EP0376852B1 (de)
JP (1) JP2731008B2 (de)
KR (1) KR900009058A (de)
AT (1) ATE90869T1 (de)
AU (1) AU617570B2 (de)
CA (1) CA2006834A1 (de)
DE (2) DE376852T1 (de)
DK (1) DK669789A (de)
ES (1) ES2034951T3 (de)
FI (1) FI896321A0 (de)
GR (1) GR910300044T1 (de)
LU (1) LU87416A1 (de)
NO (1) NO895307L (de)
NZ (1) NZ231982A (de)
PT (1) PT92747A (de)
ZA (1) ZA899961B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2649608B1 (fr) * 1989-07-12 1991-10-11 Oreal Composition cosmetique sous forme d'un gel aqueux contenant en suspension des spheroides d'une substance lipidique solide non hydrophile
DE4336407A1 (de) * 1993-10-21 1995-04-27 Rotring Int Gmbh Wasserfeste Kosmetik
FR2721210B1 (fr) * 1994-06-17 1996-08-02 Oreal Composition de nettoyage contenant des grains lipidiques.
US5540920A (en) * 1994-11-22 1996-07-30 Olin Corporation Synergistic biocide composition containing pyrithione plus an additive
US5679648A (en) * 1994-11-30 1997-10-21 The University Hospital Methods for the treatment and prevention of fungal infections by administration of 3'-deoxypurine nucleosides
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
DE19511322C2 (de) * 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
FR2737668B1 (fr) * 1995-08-08 1997-10-31 Rocher Yves Biolog Vegetale Billes a base de substances lipophiles, leur procede de fabrication et leurs applications
JPH09268118A (ja) 1996-04-01 1997-10-14 Kao Corp 肌色改善美容剤
DE19738247C2 (de) * 1997-09-02 2000-02-17 Goldwell Gmbh Haarpflegemittel
DE19952790A1 (de) * 1999-11-03 2001-05-17 Cognis Deutschland Gmbh Verfahren zur Herstellung von Fettstoffgranulaten
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
ITMI20012366A1 (it) * 2001-11-09 2003-05-09 Farmatron Ltd Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
US7927034B2 (en) 2002-05-06 2011-04-19 Pharmakodex Limited Application device for topical administration of pharmaceutical compositions and products
US8980235B2 (en) 2003-09-30 2015-03-17 Arch Chemicals, Inc. Coated metal pyrithione particles for treatment of microorganisms
US9861605B2 (en) 2011-10-24 2018-01-09 Stable Solutions Llc Enriched injectable emulsion containing selected fatty acid triglycerides
FR3075635B1 (fr) * 2017-12-22 2019-12-06 Lvmh Recherche Procede de preparation de spheroides anhydres par cryogenie
KR102446371B1 (ko) * 2019-06-11 2022-09-22 대봉엘에스 주식회사 유지 조성물 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
DE2309202A1 (de) * 1973-02-21 1974-08-29 Schering Ag Arzneiformen mit mikroverkapseltem arzneimittelwirkstoff
DE2725924C3 (de) * 1977-06-08 1980-11-06 Hobeg Hochtemperaturreaktor-Brennelement Gmbh, 6450 Hanau Verfahren zur Herstellung kugelförmiger Teilchen aus niedrigschmelzenden organischen Substanzen

Also Published As

Publication number Publication date
AU4730689A (en) 1990-07-05
DE376852T1 (de) 1991-07-04
CA2006834A1 (fr) 1990-06-29
AU617570B2 (en) 1991-11-28
JP2731008B2 (ja) 1998-03-25
DE68907335T2 (de) 1994-01-13
KR900009058A (ko) 1990-07-02
JPH02300116A (ja) 1990-12-12
LU87416A1 (fr) 1990-07-10
NZ231982A (en) 1991-03-26
ES2034951T3 (es) 1994-10-16
NO895307D0 (no) 1989-12-28
FI896321A0 (fi) 1989-12-28
GR910300044T1 (en) 1991-11-15
EP0376852A1 (de) 1990-07-04
EP0376852B1 (de) 1993-06-23
DK669789D0 (da) 1989-12-28
DK669789A (da) 1990-06-30
PT92747A (pt) 1990-06-29
ATE90869T1 (de) 1993-07-15
ES2034951T1 (es) 1993-04-16
DE68907335D1 (de) 1993-07-29
NO895307L (no) 1990-07-02

Similar Documents

Publication Publication Date Title
ZA899961B (en) Microgranulates comprising a saturated fatty acid triglyceride and an active substance,and pharmaceutical composition containing them
AU7405387A (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
HUT50624A (en) Process for producing pharmaceuical compositions with controlled release of active ingredient
DE68903442T2 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
GR3005640T3 (de)
DK555389A (da) Farmaceutisk praeparat
HUT49450A (en) Insecticides and acaricides containing as active substance derivatives of 2,2 difluor cycloprophil ethan and process for production of the active substance
NO932236D0 (no) Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
HUT44126A (en) Herbicide composition containing pyridine-monocarboxylic acid derivative with sulfur-containing group at the 5th position as active component and process for producing the active component
PH21875A (en) Novel carboxylic acid esters,their method of use and insecticides containing them as the active ingredient
NO172491C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksan-alkensyre-dervater
HUT44005A (en) Insecticide and acaricide compositions containing esters of carbamic acids as active components and process for producing the active components
IL61418A (en) Fluorine-substituted benzyl esters of 2,2,3,3-tetramethyl cyclopropane-1-carboxylic acid,their preparation and their use as pesticides
HUT45841A (en) Herbicidal compositions comprising 3-amino-2-cyano-acrylic acid ester derivatives as active ingredient and process for producing the active ingredient
HUT47895A (en) Insecticide and acaricide composition containing substituted phenyl-acetic acid ester derivatives as active components and process for producing the active components
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
SG103391G (en) Pharmaceutical formulations with controlled release of the active substance
ES8704176A1 (es) Un procedimiento para preparar hidrocloruro de bacampicili- na,protegido de la degradacion por almacenamiento en presen-cia de vapor de agua
AU1370188A (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2 and its acid addition salts for use as an active therapeutic substance
CS475388A1 (en) Mixed ester of succinic acid with 4-(3-alkoxy-3-alkyl-2-bromobutoxy)phenylalkanol and 3 beta,5-dihydroxy-5 alpha-cholestane-6-on as biologically active substance and method of its preparation